Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04729387
Title Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected
Recruitment Recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

peritoneum cancer

fallopian tube cancer

ovarian endometrial cancer

ovarian serous carcinoma

Therapies

Pegylated liposomal-doxorubicin

Paclitaxel

Alpelisib + Olaparib

Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL | AUT

Facility Status City State Zip Country Details
US Oncology Recruiting Phoenix Arizona 85016 United States Details
Arizona Oncology Associates SC Recruiting Phoenix Arizona 85710 United States Details
Highlands Oncology Group Main Recruiting Fayetteville Arkansas 72703 United States Details
Florida Cancer Specialists Dept of Oncology (2) Recruiting Fort Myers Florida 33901 United States Details
Florida Cancer Specialists Recruiting Fort Myers Florida 33901 United States Details
Florida Cancer Specialists Panhandle Recruiting Tallahassee Florida 32308 United States Details
Florida Cancer Specialists Recruiting West Palm Beach Florida 33401 United States Details
Illinois Cancer Specialists Recruiting Arlington Heights Illinois 60005 United States Details
Maryland Oncology Hematology P A Recruiting Silver Spring Maryland 20904 United States Details
Dana Farber Cancer Institute Recruiting Boston Massachusetts 02115 United States Details
Memorial Sloan Kettering Cancer Center Recruiting New York New York 10065 United States Details
Oncology Hematology Care Inc Recruiting Cincinnati Ohio 45242 United States Details
University of Cincinnati Dept of Oncology Recruiting Cincinnati Ohio 45267 United States Details
Avera Cancer Institute Recruiting Sioux Falls South Dakota 57106 United States Details
Sarah Cannon Research Institute Recruiting Nashville Tennessee 37203 United States Details
Texas Oncology, P.A. Texas Oncology - South Austin Recruiting Bedford Texas 76022 United States Details
Texas Oncology Charles A. Sammons Cancer Ctr Recruiting Dallas Texas 75246 United States Details
Texas Oncology P A Recruiting San Antonio Texas 78217 United States Details
US Oncology P A Recruiting Tyler Texas 75702 United States Details
Novartis Investigative Site Recruiting Caba Buenos Aires C1125ABD Argentina Details
Novartis Investigative Site Recruiting Bedford Park South Australia 5041 Australia Details
Novartis Investigative Site Recruiting Shepparton Victoria 3630 Australia Details
Novartis Investigative Site Recruiting Innsbruck Tyrol 6020 Austria Details
Novartis Investigative Site Recruiting Graz 8036 Austria Details
Novartis Investigative Site Recruiting Bruxelles 1000 Belgium Details
Novartis Investigative Site Recruiting Leuven 3000 Belgium Details
Novartis Investigative Site Recruiting Namur 5000 Belgium Details
Novartis Investigative Site Recruiting Sao Paulo SP 01317-002 Brazil Details
Novartis Investigative Site Recruiting Sao Paulo SP 03102-002 Brazil Details
Novartis Investigative Site Recruiting Calgary Alberta T2N 4N2 Canada Details
Novartis Investigative Site Recruiting Vancouver British Columbia V5Z 4E6 Canada Details
Novartis Investigative Site Recruiting London Ontario N6A 4L6 Canada Details
Novartis Investigative Site Recruiting Toronto Ontario M4N 3M5 Canada Details
Novartis Investigative Site Recruiting Tianjin Tianjin 300060 China Details
Novartis Investigative Site Recruiting Beijing 100036 China Details
Novartis Investigative Site Recruiting Jinan 250012 China Details
Novartis Investigative Site Recruiting Shanghai 200032 China Details
Novartis Investigative Site Recruiting Wuhan 430022 China Details
Novartis Investigative Site Recruiting Novy Jicin Czech Republic 74101 Czechia Details
Novartis Investigative Site Recruiting Brno 62500 Czechia Details
Novartis Investigative Site Recruiting Ostrava Poruba 708 52 Czechia Details
Novartis Investigative Site Recruiting Praha 2 128 51 Czechia Details
Novartis Investigative Site Recruiting Herlev Denmark Details
Novartis Investigative Site Recruiting Odense C DK 5000 Denmark Details
Novartis Investigative Site Recruiting Kuopio FIN-70211 Finland Details
Novartis Investigative Site Recruiting Tampere FIN-33521 Finland Details
Novartis Investigative Site Recruiting Turku FIN-20521 Finland Details
Novartis Investigative Site Recruiting Besancon cedex 25030 France Details
Novartis Investigative Site Recruiting Lyon Cedex 69373 France Details
Novartis Investigative Site Recruiting Paris 75012 France Details
Novartis Investigative Site Recruiting Pierre Benite Cedex 69495 France Details
Novartis Investigative Site Recruiting Villejuif Cedex 94800 France Details
Novartis Investigative Site Recruiting Mannheim Baden-Wuerttemberg 68305 Germany Details
Novartis Investigative Site Recruiting Berlin 13353 Germany Details
Novartis Investigative Site Recruiting Dresden 01307 Germany Details
Novartis Investigative Site Recruiting Mainz 55131 Germany Details
Novartis Investigative Site Recruiting Bologna BO 40138 Italy Details
Novartis Investigative Site Recruiting Milano MI 20133 Italy Details
Novartis Investigative Site Recruiting Milano MI 20141 Italy Details
Novartis Investigative Site Recruiting Roma RM 8-00168 Italy Details
Novartis Investigative Site Recruiting Vicenza VI 36100 Italy Details
Novartis Investigative Site Recruiting Napoli 80131 Italy Details
Novartis Investigative Site Recruiting Seoul 03080 Korea, Republic of Details
Novartis Investigative Site Recruiting Seoul 03722 Korea, Republic of Details
Novartis Investigative Site Recruiting Kota Kinabalu Sabah 88996 Malaysia Details
Novartis Investigative Site Recruiting Kuching Sarawak 93586 Malaysia Details
Novartis Investigative Site Recruiting Kuala Lumpur Wilayah Persekutuan 50586 Malaysia Details
Novartis Investigative Site Recruiting Kuala Lumpur 59100 Malaysia Details
Novartis Investigative Site Recruiting Monterrey Nuevo Leon 64460 Mexico Details
Novartis Investigative Site Recruiting Ciudad de Mexico 04700 Mexico Details
Novartis Investigative Site Recruiting Eindhoven 5623 EJ Netherlands Details
Novartis Investigative Site Recruiting Porto 4200-072 Portugal Details
Novartis Investigative Site Active, not recruiting Arkhangelsk 163045 Russian Federation Details
Novartis Investigative Site Withdrawn Ufa 450054 Russian Federation Details
Novartis Investigative Site Recruiting Singapore 119228 Singapore Details
Novartis Investigative Site Recruiting Singapore 169610 Singapore Details
Novartis Investigative Site Recruiting Bratislava 83310 Slovakia Details
Novartis Investigative Site Recruiting Trencin 91171 Slovakia Details
Novartis Investigative Site Recruiting Cordoba Andalucia 14004 Spain Details
Novartis Investigative Site Recruiting Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Recruiting Barcelona Catalunya 08036 Spain Details
Novartis Investigative Site Recruiting Valencia Comunidad Valenciana 46010 Spain Details
Novartis Investigative Site Recruiting Pamplona Navarra 31008 Spain Details
Novartis Investigative Site Recruiting Madrid 28034 Spain Details
Novartis Investigative Site Recruiting Taichung 40705 Taiwan Details
Novartis Investigative Site Recruiting Taipei 10002 Taiwan Details
Novartis Investigative Site Recruiting Taipei 11217 Taiwan Details
Novartis Investigative Site Recruiting Adana 01160 Turkey Details
Novartis Investigative Site Recruiting Ankara 06100 Turkey Details
Novartis Investigative Site Recruiting Ankara 06520 Turkey Details
Novartis Investigative Site Recruiting Istanbul 34214 Turkey Details
Novartis Investigative Site Recruiting Izmir Turkey Details
Novartis Investigative Site Recruiting Trabzon 61080 Turkey Details
Novartis Investigative Site Recruiting Glasgow G12 0YN United Kingdom Details
Novartis Investigative Site Recruiting Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field